Enola buys BIIB 289.53: Richard A. Rudick Joins Biogen Idec as Vice President, Development Sciences, Value-Based Medicine
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Biogen Idec (NASDAQ: BIIB) today announced that Richard (Rick) A. Rudick, M.D., has joined the company as vice president, Development Sciences, Value-Based Medicine. Dr. Rudick will lead Biogen Idecâs newly created ... ...
27 people liked this
0 Comments:
Post a Comment
Subscribe to Post Comments [Atom]
<< Home